| pubmed-article:4008552 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C0017953 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C0041942 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C0037638 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C0008565 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:4008552 | lifeskim:mentions | umls-concept:C1998793 | lld:lifeskim |
| pubmed-article:4008552 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:4008552 | pubmed:dateCreated | 1985-8-1 | lld:pubmed |
| pubmed-article:4008552 | pubmed:abstractText | Reversed-phase high-performance liquid chromatography was used to purify an inhibitory glycopeptide where resolution and recovery were enhanced by using urea or guanidine-HCl-isopropanol-water as a solvent system. Isopropanol alone or other solvent systems that have been proposed for such purification steps were not effective in eluting hydrophobic proteins from the reversed-phase column. The application of the urea or guanidine-HCl solvent systems in the separation and purification of membrane proteins, and other hydrophobic macromolecules, could greatly enhance recovery and efficiency of purification. | lld:pubmed |
| pubmed-article:4008552 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4008552 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008552 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4008552 | pubmed:month | May | lld:pubmed |
| pubmed-article:4008552 | pubmed:issn | 0021-9673 | lld:pubmed |
| pubmed-article:4008552 | pubmed:author | pubmed-author:JohnsonT CTC | lld:pubmed |
| pubmed-article:4008552 | pubmed:author | pubmed-author:BascomC CCC | lld:pubmed |
| pubmed-article:4008552 | pubmed:author | pubmed-author:SharifiB GBG | lld:pubmed |
| pubmed-article:4008552 | pubmed:author | pubmed-author:KhuranaV KVK | lld:pubmed |
| pubmed-article:4008552 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4008552 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:4008552 | pubmed:volume | 324 | lld:pubmed |
| pubmed-article:4008552 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4008552 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4008552 | pubmed:pagination | 173-80 | lld:pubmed |
| pubmed-article:4008552 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:meshHeading | pubmed-meshheading:4008552-... | lld:pubmed |
| pubmed-article:4008552 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:4008552 | pubmed:articleTitle | Use of a urea and guanidine-HCl-propanol solvent system to purify a growth inhibitory glycopeptide by high-performance liquid chromatography. | lld:pubmed |
| pubmed-article:4008552 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:4008552 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:4008552 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
